Improved outcome of 131I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma.

about

Improved outcome of 131I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma.

Item

http://www.wikidata.org/entity/Q42374792

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Improved outcome of 131I-mIBG ...... mouse model of neuroblastoma.

@en

Improved outcome of 131I-mIBG ...... mouse model of neuroblastoma.

@nl

type

Item

label

Improved outcome of 131I-mIBG ...... mouse model of neuroblastoma.

@en

Improved outcome of 131I-mIBG ...... mouse model of neuroblastoma.

@nl

prefLabel

Improved outcome of 131I-mIBG ...... mouse model of neuroblastoma.

@en

Improved outcome of 131I-mIBG ...... mouse model of neuroblastoma.

@nl

P1476

Improved outcome of 131I-mIBG ...... mouse model of neuroblastoma.

@en

P2093

Boris Vojnovic

http://www.w3.org/2001/XMLSchema#string

Christiana Kartsonaki

http://www.w3.org/2001/XMLSchema#string

Danny P Allen

http://www.w3.org/2001/XMLSchema#string

James Thompson

http://www.w3.org/2001/XMLSchema#string

Javian Malcolm

http://www.w3.org/2001/XMLSchema#string

Mark A Hill

http://www.w3.org/2001/XMLSchema#string

Mark N Gaze

http://www.w3.org/2001/XMLSchema#string

Paul Kinchesh

http://www.w3.org/2001/XMLSchema#string

Sean C Smart

http://www.w3.org/2001/XMLSchema#string

P2860

NIH Image to ImageJ: 25 years of image analysis

Radioimmunotherapy of colorectal cancer liver metastases: combination with radiotherapy.

External beam radiation therapy (EBRT) for patients with malignant pheochromocytoma and non-head and -neck paraganglioma: combination with 131I-MIBG.

Improving external beam radiotherapy by combination with internal irradiation

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.

Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen species

Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma.

A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma.

Planning combined treatments of external beam radiation therapy and molecular radiotherapy.

Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.

P304

488-495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.RADONC.2017.05.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Aurélien Corroyer-Dulmont

P577

2017-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28595752

http://www.w3.org/2001/XMLSchema#string

P932

5636618

http://www.w3.org/2001/XMLSchema#string